Prescient Healthcare Group

Prescient Healthcare Group provides strategic consulting and evidence-based decision support to global biopharmaceutical companies across the full drug lifecycle, from preclinical through commercialization and loss of exclusivity. The firm specializes in product development strategy, market research and analysis, business development/licensing support, and portfolio management for pharma/biotech clients.

It has no clinical results or pipeline as it does not itself sponsor or conduct clinical trials.

In May 2025 it became a Certified B Corporation™, reflecting its commitment to social/environmental standards.

Over 70% of employees hold advanced life sciences degrees. Clients include top global biopharma companies.

The company operates three centers of excellence—Commercial, Medical, Insights—to address client needs at all stages of the product lifecycle.

It supports products in oncology, hematology, immunology, respiratory disease, cardiology/metabolic disease, neurosciences and infectious diseases. Also active in biosimilars/generics/vaccines/rare diseases consulting.

As a consultancy/advisory firm it has no therapeutic pipeline.